- Filed
- Feb 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 12, 2024 | 5.13B sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $34.72M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $37.19M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $610.89K |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $340.25K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $620.1K |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $376.98K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $45.5M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $48.03M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $48.66M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $51.21M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 5.39B sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 5.33B sh |
| Capex | Q2 2024 · Dec 31, 2022 | $33.81K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$2.71M |
| Stockholders Equity restated | Q2 2024 · Dec 31, 2022 | $31.37M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $22.84M |
| Stockholders Equity restated | Q2 2024 · Jun 30, 2022 | $23.74M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.00 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $3.28M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $3.51M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $1.77M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $2.08M |
| Net Income | Q2 2024 · Dec 31, 2022 | $4.6M |
| Net Income | Q2 2024 · Dec 31, 2022 | $3.7M |
| Net Income | Q2 2024 · Sep 30, 2022 | −$896.95K |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$5.06M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$5.7M |